These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 27470241

  • 1. Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration.
    Crellen T, Walker M, Lamberton PH, Kabatereine NB, Tukahebwa EM, Cotton JA, Webster JP.
    Clin Infect Dis; 2016 Nov 01; 63(9):1151-1159. PubMed ID: 27470241
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya.
    Abudho BO, Guyah B, Ondigo BN, Ndombi EM, Ireri E, Carter JM, Riner DK, Kittur N, Karanja DMS, Colley DG.
    Infect Dis Poverty; 2020 Jun 15; 9(1):67. PubMed ID: 32539826
    [Abstract] [Full Text] [Related]

  • 3. Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections.
    Karanja DMS, Awino EK, Wiegand RE, Okoth E, Abudho BO, Mwinzi PNM, Montgomery SP, Secor WE.
    PLoS Negl Trop Dis; 2017 Oct 15; 11(10):e0006033. PubMed ID: 29059190
    [Abstract] [Full Text] [Related]

  • 4. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL, Diaw OT, Seye MM, Faye DS, Stothard JR, Sousa-Figueiredo JC, Rollinson D.
    Acta Trop; 2013 Nov 15; 128(2):292-302. PubMed ID: 23022016
    [Abstract] [Full Text] [Related]

  • 5. Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.
    Faust CL, Crotti M, Moses A, Oguttu D, Wamboko A, Adriko M, Adekanle EK, Kabatereine N, Tukahebwa EM, Norton AJ, Gower CM, Webster JP, Lamberton PHL.
    Parasit Vectors; 2019 Dec 27; 12(1):607. PubMed ID: 31881923
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
    Bajiro M, Dana D, Ayana M, Emana D, Mekonnen Z, Zawdie B, Garbi A, Kure A, Zeynudin A.
    Parasit Vectors; 2016 Oct 24; 9(1):560. PubMed ID: 27772528
    [Abstract] [Full Text] [Related]

  • 7. Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda.
    Frenzel K, Grigull L, Odongo-Aginya E, Ndugwa CM, Loroni-Lakwo T, Schweigmann U, Vester U, Spannbrucker N, Doehring E.
    Am J Trop Med Hyg; 1999 Jun 24; 60(6):927-31. PubMed ID: 10403322
    [Abstract] [Full Text] [Related]

  • 8. Praziquantel efficacy against schistosomiasis mansoni in schoolchildren in north-west Ethiopia.
    Degu G, Mengistu G, Jones J.
    Trans R Soc Trop Med Hyg; 2002 Jun 24; 96(4):444-5. PubMed ID: 12497985
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of oxamniquine and praziquantel in school children from two Schistosoma mansoni endemic areas.
    Thiong'o FW, Mbugua GG, Ouma JH, Sturrock RK.
    East Afr Med J; 2002 Jan 24; 79(1):29-33. PubMed ID: 12380867
    [Abstract] [Full Text] [Related]

  • 10. Increasing teacher motivation and supervision is an important but not sufficient strategy for improving praziquantel uptake in Schistosoma mansoni control programs: serial cross sectional surveys in Uganda.
    Muhumuza S, Katahoire A, Nuwaha F, Olsen A.
    BMC Infect Dis; 2013 Dec 13; 13():590. PubMed ID: 24330594
    [Abstract] [Full Text] [Related]

  • 11. Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial Schistosoma mansoni Infection Prevalence: A Cluster Randomized Trial.
    Secor WE, Wiegand RE, Montgomery SP, Karanja DMS, Odiere MR.
    Am J Trop Med Hyg; 2020 Feb 13; 102(2):318-327. PubMed ID: 31802733
    [Abstract] [Full Text] [Related]

  • 12. Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.
    Abudho BO, Ndombi EM, Guya B, Carter JM, Riner DK, Kittur N, Karanja DMS, Secor WE, Colley DG.
    Am J Trop Med Hyg; 2018 May 13; 98(5):1397-1402. PubMed ID: 29532768
    [Abstract] [Full Text] [Related]

  • 13. Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial.
    Nalugwa A, Nuwaha F, Tukahebwa EM, Olsen A.
    PLoS Negl Trop Dis; 2015 May 13; 9(5):e0003796. PubMed ID: 26011733
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A, Lamine MS, Barkiré N, Djibo A, Sofo B, Gouvras AN, Labbo R, Sebangou H, Webster JP, Fenwick A, Utzinger J.
    Acta Trop; 2013 Nov 13; 128(2):334-44. PubMed ID: 22940014
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia.
    Erko B, Degarege A, Tadesse K, Mathiwos A, Legesse M.
    Asian Pac J Trop Biomed; 2012 Mar 13; 2(3):235-9. PubMed ID: 23569905
    [Abstract] [Full Text] [Related]

  • 16. Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection.
    William S, Guirguis F, Nessim NG.
    Arzneimittelforschung; 2003 Mar 13; 53(7):532-7. PubMed ID: 12918221
    [Abstract] [Full Text] [Related]

  • 17. Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania.
    Norton AJ, Gower CM, Lamberton PH, Webster BL, Lwambo NJ, Blair L, Fenwick A, Webster JP.
    Am J Trop Med Hyg; 2010 Oct 13; 83(4):951-7. PubMed ID: 20889898
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection.
    Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Tanner M.
    Trop Med Int Health; 2000 Nov 13; 5(11):771-8. PubMed ID: 11123824
    [Abstract] [Full Text] [Related]

  • 19. Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.
    Ndombi EM, Abudho B, Kittur N, Carter JM, Korir H, Riner DK, Ochanda H, Lee YM, Secor WE, Karanja DM, Colley DG.
    Parasite Immunol; 2018 Jun 13; 40(6):e12530. PubMed ID: 29604074
    [Abstract] [Full Text] [Related]

  • 20. Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study.
    French MD, Churcher TS, Gambhir M, Fenwick A, Webster JP, Kabatereine NB, Basáñez MG.
    PLoS Negl Trop Dis; 2010 Nov 23; 4(11):e897. PubMed ID: 21124888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.